Innovation

Cracks through the ice on a melting glacier in Alaska
News

OHE Involved in Developing New AMS Report on Stratified Medicines

15 July 2013

Professor Adrian Towse, OHE’s Director, joined Professor Sir John Bell and Professor Andrew Morris at the Science Media Centre last week to launch Realising the Potential…

The Challenges and Economics of Drug Development in 2022
News

Forecasting the Challenges and Economics of Drug Development in 2022

9 July 2013

A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for…

Cracks through the ice on a melting glacier in Alaska
News

Defining Innovation in Medicines and Transforming it into Value

3 July 2013

In June, OHE’s Jorge Mestre-Ferrandiz participated as a speaker at the Summer Course on the Evaluation of Medicines at the University of Alcalá in Spain. His…

Cracks through the ice on a melting glacier in Alaska
News

Critical Factors Affecting Pharmaceutical R&D and the Availability of New Drugs

18 June 2013

Dr Jorge Mestre-Ferrandiz, OHE’s Director of Consulting, was a recent guest lecturer at Imperial College London. His comprehensive presentation covered the gamut of issues that influence…

Cracks through the ice on a melting glacier in Alaska
News

OHE’s Towse on Challenges in Valuing Genomic Medicines

23 May 2013

In this video, Adrian Towse discusses the challenges and importance of appropriately valuing genomic medicine. He addresses both gene therapies and “pharmacogenomics” — those medicines that…

Cracks through the ice on a melting glacier in Alaska
News

Valuing Co-Dependent Medical Technologies: Improving Methods and Processes

23 April 2013

Advances in science and technology are producing more and better means for diagnosing disease, matching patients to the best therapies, and tracking the progress of treatment.…

Cracks through the ice on a melting glacier in Alaska
News

The Economics of the Market for Medicines: 2013 Review

26 March 2013

OHE’s Dr Jorge Mestre-Ferrandiz is a visiting lecturer in the Department of Economics at City University London. As part of his 2013 activities, he recently gave…

The R&D Cost of a New Medicine
News

Overview of the OHE Study on the Cost of Drug Development Presented

29 January 2013

OHE’s Jorge Mestre-Ferrandiz reviewed the results of OHE’s recent study on the R&D cost of developing a new drug at a seminar at University College London.…

390 - Influence-of-cost-effectiveness-NICE-Dakin-2013-NEW
Publication

The Influence of Cost-effectiveness and Other Factors on NICE Decisions

1 November 2013

In this Research Paper, the authors explore which factors have most influenced NICE decisions from 1999 through the end of 2011. The research has two objectives:…